Navigation Links
Abbott Scientists Create One Molecule With Two Antibody Functions
Date:10/18/2007

First Combination of Large Molecules to Show Drug-like Properties and

Manufacturing Feasibility

ABBOTT PARK, Ill., Oct. 18 /PRNewswire-FirstCall/ -- Abbott (NYSE: ABT) reported today that its scientists are the first to discover a proprietary technology that combines the function and specificity of two or more monoclonal antibodies (mAbs) into one molecular entity that demonstrates drug-like properties and manufacturing feasibility. These molecules, called dual-variable domain Ig (DVD-Ig(TM)) (http://www.abbott.com/global/url/content/en_US/60.15:15/feature/Feature_0029.htm) , will allow for development of individual drug candidates that target multiple disease-causing molecules in various therapeutic categories.

Published online earlier this week in Nature Biotechnology (http://www.nature.com/nbt/journal/vaop/ncurrent/full/nbt1345.html), this landmark study demonstrates a completely new platform that may be relevant to cancer, autoimmune diseases and other complicated conditions in which multiple disease-mediators are at play. Simultaneous blockage of multiple targets using DVD-Ig agents may increase efficacy in comparison to inhibition of a single target using a mAb.

"Combining the specificity of two or more antibodies into one drug has been a significant challenge for researchers looking at next generation biologic therapies," said Abbott Scientists Chengbin Wu, Ph.D. and Tariq Ghayur, Ph.D., who designed the DVD-Ig molecules and led the research team. "Abbott's approach is
'/>"/>

SOURCE Abbott
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Abbott vs. Thailand has implications for innovation and access
2. A prognosis for GE and Abbott Diagnostics
3. Wisconsin court halts Abbotts sale of genotyping products
4. Wisconsin court affirms damages in Innogenetics, Abbott patent case
5. Abbott Labs campus in Kenosha could send ripples through local biotech
6. Abbott Executive Jim Tyree Takes IBIO Helm
7. Promega Announces Agreement with Abbott
8. UW computer scientists fighting computer virus "Cold War"
9. Scientists find way to make human collagen in lab
10. Wisconsin scientists to be recognized for innovative biofuel technology
11. UW-Madison scientists to mimic nature for newest cancer drugs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... 1, 2015   Decision Resources Group ... of Otezla are its oral administration, alternative mechanism ... by surveyed rheumatologists. Otezla was the first oral ... of active psoriatic arthritis in the ... care includes conventional oral treatments including disease-modifying antirheumatic ...
(Date:7/1/2015)... 2015 Isagenix International, a leading global health ... three Silver, and three Bronze Stevie® Awards at the ... Chicago this month.The American Business ... program in the U.S. "Winning is ... developing leaders, cultivating talent, creating a unified team, and ...
(Date:7/1/2015)... YORK , July 1, 2015  UCB, ... G ), a global leader in designing, transforming, ... Aecus Innovation Award in recognition of their close ... efficiencies in UCB,s global business services (GBS) finance ... service providers and clients that work together effectively ...
(Date:6/30/2015)... , June 30, 2015  NASA astronaut Kjell ... next month on his first mission to the International ... from 8 to 9 a.m. EDT Tuesday, July 7. ... in Star City, Russia . The interviews ... NASA Television highlighting his mission training. To schedule ...
Breaking Biology Technology:Surveyed Rheumatologists Report That Otezla's Oral Administration is its Single Greatest Advantage Over Currently Available Treatment Options 2Surveyed Rheumatologists Report That Otezla's Oral Administration is its Single Greatest Advantage Over Currently Available Treatment Options 3Isagenix Earns Nine American Business Awards 2Isagenix Earns Nine American Business Awards 3UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services 2UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services 3UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services 4UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services 5NASA Astronaut Preps for First Space Station Mission, Available for Media Interviews 2
... Cardium Therapeutics (NYSE Alternext US: CXM) and its ... the first patient in a study of Hypothermic Radical ... University of California, Irvine . The patient was ... designed to induce localized cooling during robotic-assisted prostatectomy surgery. ...
... Sciences, Inc., a,privately-held, development-stage pharmaceutical company dedicated to ... mucosal defenses, today,announced that the National Institutes of ... in excess of $850,000. , ... is to advance the development of safe and,effective ...
... CARMEL, Israel, December 16 InSightec Ltd.,announced today ... that,have spread to their bones have a new ... http://www.MyCancerPain.org , provides,background on bone metastases, as ... conducted at eleven centers in the U.S., Canada ...
Cached Biology Technology:Cardium's InnerCool Announces First Patient Treated With New Tissue-Specific UroCool(TM) System in Robotic-Assisted Prostate Surgery Study 2Cardium's InnerCool Announces First Patient Treated With New Tissue-Specific UroCool(TM) System in Robotic-Assisted Prostate Surgery Study 3Cardium's InnerCool Announces First Patient Treated With New Tissue-Specific UroCool(TM) System in Robotic-Assisted Prostate Surgery Study 4Cardium's InnerCool Announces First Patient Treated With New Tissue-Specific UroCool(TM) System in Robotic-Assisted Prostate Surgery Study 5Cardium's InnerCool Announces First Patient Treated With New Tissue-Specific UroCool(TM) System in Robotic-Assisted Prostate Surgery Study 6Cardium's InnerCool Announces First Patient Treated With New Tissue-Specific UroCool(TM) System in Robotic-Assisted Prostate Surgery Study 7Cardium's InnerCool Announces First Patient Treated With New Tissue-Specific UroCool(TM) System in Robotic-Assisted Prostate Surgery Study 8Parion Sciences Receives NIH Biodefense Grant to Study Novel Methods for Mitigating Radiation-Induced Lung Injury 2Parion Sciences Receives NIH Biodefense Grant to Study Novel Methods for Mitigating Radiation-Induced Lung Injury 3MyCancerPain.org Launched as Resource for Patients with Painful Bone Metastases 2MyCancerPain.org Launched as Resource for Patients with Painful Bone Metastases 3
(Date:6/17/2015)... , Deutschland und GERMANTOWN, Maryland , ... ®   Produktlinie mit DNA-Tests verbessert ... N.V. (NASDAQ: QGEN ; Frankfurt Prime Standard: QIA) ... neue STR-Testkits der Produktlinie Investigator ® ... den Markt eingeführt. Die neuen Kits zur Erstellung genetischer ...
(Date:6/16/2015)... -- With the increasing number and severity of data breaches ... recent compromise of Federal employee data from OPM,s ... government agencies. HYPR Corp. announced today that ... has been submitted for testing and approval of Federal ... tamper proofing. The proliferation of security ...
(Date:6/15/2015)... Conn. , Jun. 15, 2015 NXT-ID, Inc. (NASDAQ: ... company focused on the growing mobile commerce market, announces that ... be showcased to media at Digital Experience! @ NYC June ... summer showcase of the latest innovation in technology to over ... will be held at the Metropolitan Pavilion in ...
Breaking Biology News(10 mins):QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 2QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 3QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 4QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 5QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 6Government Ready Biometric Security Approaching as HYPR Corp. Files FIPS 140-2 Level 3 Validation for Its Proprietary Biometric Token 2Government Ready Biometric Security Approaching as HYPR Corp. Files FIPS 140-2 Level 3 Validation for Its Proprietary Biometric Token 3Wocket Smart Wallet Exhibiting at Pepcom Digital Experience! @ NYC June 18th 2Wocket Smart Wallet Exhibiting at Pepcom Digital Experience! @ NYC June 18th 3
... shows that bacteria lurking in household dust produce ... such as wheezing. These bacterial chemicals, called endotoxins, ... with increased respiratory problems in adults. This study, ... Sciences (NIEHS), a part of the National Institutes ...
... basis of human diseaseHigh-throughput sequencing of an individual's DNA ... clues to the genetic underpinning of human disease. ... individual's two chromosomes. Yet many scientists believe that ... the level of each chromosome -- so-called haplotypes -- ...
... insight into genetic basis of human diseaseHigh-throughput sequencing of ... which can give clues to the genetic underpinning of ... information from the individual's two chromosomes. Yet many ... individuals' DNA at the level of each chromosome -- ...
Cached Biology News:Bacteria in Household Dust May Trigger Asthma Symptoms 2Bacteria in Household Dust May Trigger Asthma Symptoms 3U-M scientists say fused genes trigger the development of prostate cancer 2U-M scientists say fused genes trigger the development of prostate cancer 3U-M scientists say fused genes trigger the development of prostate cancer 4California computer scientists double volume of data in NIH biotech repository 2California computer scientists double volume of data in NIH biotech repository 3California computer scientists double volume of data in NIH biotech repository 4
Recombinant Viral CCI/Fc Chimera, CF...
... Guinea Pig Serum • Guinea Pig serum ... Available Anticoagulants: N-02: Citrate ... N-08: Potassium Oxalate N-10: ... ACD N-07: CPD N-09: ...
GENOMIPHI V2 DNA AMP KIT 25RXN, 1 EA. Category: Genomics DNA Amplification....
EPH electrode, anode, 1. Category: Electrophoresis Systems & Standards & Reagents, IEF & SDS-PAGE & 2-D Electrophoresis, Multiphor II Kits & Components and Accessories....
Biology Products: